Journal of Bacteriology, December 2001, p. 6979-6990, Vol. 183, No. 24
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.24.6979-6990.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Howard Hughes Medical Institute, Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461,1 and Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina 27599-72902
Received 22 June 2001/Accepted 18 September 2001
| |
ABSTRACT |
|---|
|
|
|---|
The proper extracytoplasmic localization of proteins is an
important aspect of mycobacterial physiology and the pathogenesis of
Mycobacterium tuberculosis. The protein export systems
of mycobacteria have remained unexplored. The Sec-dependent protein
export pathway has been well characterized in Escherichia
coli and is responsible for transport across the cytoplasmic
membrane of proteins containing signal sequences at their amino
termini. SecA is a central component of this pathway, and it is highly
conserved throughout bacteria. Here we report on an unusual property of
mycobacterial protein export
the presence of two homologues of SecA
(SecA1 and SecA2). Using an allelic-exchange strategy in
Mycobacterium smegmatis, we demonstrate that
secA1 is an essential gene. In contrast,
secA2 can be deleted and is the first example of a
nonessential secA homologue. The essential nature of
secA1, which is consistent with the conserved Sec
pathway, leads us to believe that secA1 represents the
equivalent of E. coli secA. The results of a phenotypic analysis of a
secA2 mutant of M.
smegmatis are presented here and also indicate a role for SecA2
in protein export. Based on our study, it appears that SecA2 can assist
SecA1 in the export of some proteins via the Sec pathway. However,
SecA2 is not the functional equivalent of SecA1. This finding, in
combination with the fact that SecA2 is highly conserved throughout
mycobacteria, suggests a second role for SecA2. The possibility exists
that another role for SecA2 is to export a specific subset of proteins.
| |
INTRODUCTION |
|---|
|
|
|---|
Mycobacterium tuberculosis is the causative agent of tuberculosis and represents a severe health threat throughout the world. Nearly three million people die each year from tuberculosis (51). M. tuberculosis is an intracellular pathogen that is able to survive and grow in macrophages. Secreted and cell surface-associated proteins are ideally positioned to act on the host macrophage and enable survival of the bacillus in this normally hostile antimicrobial environment. In support of this hypothesis, the exported repetitive protein (Erp) has been shown to participate in the pathogenesis of M. tuberculosis (2). An erp mutant of M. tuberculosis is attenuated in mice and exhibits a significantly reduced ability to grow in macrophages. However, the specific role of Erp in the intracellular survival strategy of M. tuberculosis is unknown.
Protein export is an important aspect of bacterial pathogenesis. Research on diverse bacterial pathogens has demonstrated that the majority of virulence factors are extracytoplasmic proteins (20, 29). Recently, the importance of protein export pathways to pathogenicity has been underscored by the identification of specialized secretion pathways (types I, II, III, and IV) in numerous bacterial pathogens. There are many examples of these types of export pathways being encoded in pathogenicity islands and being required for the proper localization of specific virulence factors (28).
Surprisingly little is known about the protein export pathways of mycobacteria (4). In contrast, the protein export pathways of other bacteria are better characterized, most notably in Escherichia coli (11, 15). The Sec-dependent protein export pathway is responsible for the transport of the majority of extracytoplasmic proteins in E. coli; consequently, this export system represents an essential function of the cell (16). The proteins translocated across the cytoplasmic membrane by the Sec pathway are initially synthesized as precursor proteins containing conserved amino-terminal signal sequences. These precursor proteins are routed to the translocase, the channel through which translocating proteins travel across the membrane. During translocation, the signal sequence is cleaved off by a signal peptidase to generate the mature exported protein. The translocase core is composed of integral membrane proteins SecY and SecE and the peripheral membrane protein SecA. SecA plays a central and essential role in this export pathway. It is an ATPase that provides energy for protein translocation. In addition, SecA binds to nearly all of the components of the Sec pathway, including precursor proteins, chaperones such as SecB, acidic phospholipids in the membrane, and integral membrane components of the translocase (15, 33, 43). Through cycles of ATP binding and hydrolysis, SecA delivers bound precursor proteins to the translocase and undergoes cycles of membrane insertion and deinsertion that lead to stepwise export of the protein (18, 42, 50). Additional proteins, SecG and the complex of SecD, SecF, and YajC, are not essential to Sec-dependent export but serve to increase the overall efficiency of the process (14). The Sec-dependent export pathway is highly conserved among different bacteria (39, 43).
In order to begin understanding the protein export pathways that operate in mycobacteria, we set out to identify and characterize SecA. To our surprise, there are two homologues of secA in mycobacteria, referred to as secA1 and secA2. This was an unexpected finding, as no other fully sequenced genome, among those available at the time, had revealed the existence of two secA genes in a single organism. In this report, we present a genetic analysis in Mycobacterium smegmatis, a fast-growing and nonpathogenic mycobacteria, that demonstrates that the two mycobacterial secA genes are not redundant and that both function in the cell.
Very recently, the Staphylococcus aureus and Streptococcus pneumoniae genomes provided two additional examples of bacteria that possess two secA genes (24, 27, 48). The presence of two SecA proteins may represent a new type of specialized protein export pathway.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and culture methods.
All of the strains
used in this work are described in Table
1. E. coli strain DH5
was
used for DNA cloning procedures. For culturing of E. coli,
Luria-Bertani (LB) broth or agar (Difco) was used. When required, the
following antibiotics were used for E. coli strains:
kanamycin at 40 µg/ml and carbenicillin at 50 µg/ml. A variety of
media were employed for the growth of M. smegmatis and
included all of the following: Middlebrook 7H9 broth (Difco) with 0.2%
glycerol, 0.5% dextrose, and 0.1% Tween 80; the same medium
supplemented with 0.2% glycerol, 1× ADS (0.5% bovine serum albumin,
fraction V [Boehringer Mannheim], 0.2% dextrose, 0.85% NaCl), and
0.1% Tween 80; LB broth with 0.1% Tween 80; 7H10 agar with 0.2%
dextrose and 0.05% Tween 80; LB agar with 0.2% dextrose; and
Mueller-Hinton agar (Difco). When appropriate, sucrose was incorporated into 7H10 plates at a concentration of 4.5%. When required, the following antibiotics were used to grow M. smegmatis strains: kanamycin at 20 µg/ml and hygromycin B at 50 µg/ml. When appropriate, cultures were grown overnight in Middlebrook
7H9 with 0.2% glycerol, 1× ADS, 0.1% Tween 80, and 100 µM sodium
azide.
|
DNA methodologies. Standard molecular biology techniques for cloning were employed as previously described (41). Restriction enzymes and Vent polymerase were obtained from New England Biolabs, Inc. The Expand high fidelity PCR system was obtained from Boehringer Mannheim. Dimethyl sulfoxide (1.0 to 10.0%) was included in selected PCRs. DNA sequencing was performed by conventional and automated methods. Automated sequencing employed the Applied Biosystems Big Dye Terminator Cycle Sequencing kit (Perkin-Elmer) and an Applied Biosystems 377 sequencer. Sequence assembly was carried out with the MacVector and Assembly Align software (Genetics Computer Group).
Plasmid construction.
The plasmids used in this study are
described in Table 2.
|
Cloning and sequencing of secA1 homologues. Degenerate oligonucleotide primers were designed to regions of identity in the secA genes of E. coli, Bacillus subtilis, and Pavlova lutherii. The 5' primer (5'-ACN-GGN-GAX-GGN-AAX-ACN-YT-3') was designed from the peptide TGEGKT (amino acids 104 to 109 of the E. coli sequence), and the 3' primer (5'-AXX-TAX-TCX-AAN-CC-3') was designed from the peptide GFDYL (amino acids 183 to 187 of the E. coli sequence), where N = GAT or C, X = G or A, and Y = C or T. These primers were employed in a touchdown PCR (40) to amplify 250-bp products from M. bovis BCG and M. smegmatis genomic DNAs.
To clone the full-length genes, the resulting PCR products were used as probes to screen the appropriate libraries. The M. bovis BCG product was used to screen a pKSII+::M. bovis BCG library (7). One hybridizing clone, pH.3, was subjected to exonuclease digestion to generate a collection of nested deletions, by using the Erase-A-Base system (Promega), that were then sequenced. The M. smegmatis product was used to screen a pYUB282::mc2155 cosmid library (kind gift of V. Balasubramanian). A 4.0-kb fragment from one hybridizing clone, pYUB495, was subcloned into pKSII+ to generate pYUB536. Nested deletions of pYUB536 were constructed with the Erase-A-Base system and sequenced.Cloning and sequencing of secA2 homologues. Full-length M. tuberculosis secA2 was amplified by PCR from M. tuberculosis H37Rv genomic DNA by using primers SecAS14 (5' TCGGATC-CAGCGGAACACCCCGGGCAGACT) and SecAS15 (5'GCGGATCCAGTGCACGGTTGTCCACGAATTGC). The PCR product was cloned into the pCR2.1 vector by using the TA cloning kit (Invitrogen) to generate pMB144. This PCR product was used to probe a pYUB412::M. smegmatis genomic cosmid library (kind gift of F. C. Bange) under low-stringency conditions. A 6.0-kb fragment from one hybridizing clone, p6-1, was subcloned into pSKII+ to generate pMB148. Nested deletions of pMB148 were constructed with the Erase-A-Base system and used to generate the sequence of secA2 (M. smegmatis).
To clone M. smegmatis secA2 under the control of the constitutive hsp60 promoter, the gene was amplified by PCR from M. smegmatis mc2155 genomic DNA. The primers used were SmSecA2-14 (5'ACGGATCCA-GTGGCGAATGAGTCCTGGCGAAC) and SmSecA2-13 (5'CGTCTTCCATGCCTAGAACCTAATG). The resulting PCR product was cloned in pCR2.1 to create pMB207. The BamHI fragment containing secA2 was then subcloned into pMV261 to create pMB208.Construction of
secA suicide plasmids. (i)
secA1 suicide plasmid pMB128.
An approximately
12.0-kb SacI fragment of pYUB495 containing secA1
of M. smegmatis was identified by Southern analysis.
Restriction digest analysis showed that secA1 is located
near the middle of this fragment. This fragment was cloned into pKSII+
to generate plasmid pMB117. pMB117 was linearized with BglII
(a unique site near the middle of secA1) and then subjected
to exonuclease III digestion in both directions outward from the
BglII-cut site by using the Erase-A-Base system and
self-ligated. One of the resulting deletion constructs, pMB120, was
analyzed by PCR and sequencing analysis and shown to contain a 1,278-bp
in-frame deletion of the secA1 gene. The large
SacI fragment of pMB120 was subcloned into pSKII+ to create
pMB125. The in-frame unmarked secA1 deletion fragment was
then cloned into counterselectable suicide vector pYUB657
(37). This was achieved by cutting pMB125 with
SpeI and ScaI and cloning the resulting
secA1 fragment into SpeI- and ScaI-cut
pYUB657. The final vector produced was pMB128.
(ii)
secA2 suicide plasmid pMB160.
A
3.2-kb BamHI-ScaI fragment of pMB148 was cloned
into BamHI-EcoRV-cut pKSII+ to generate pMB155.
pMB155 was used as the template in an inverse PCR using primers
SmSecA2-5 (5'-ACTGATATCGCGCAGCACGTCGAAGCCGAT-3') and SmSecA2-6
(5'-TGAGATATCGTCGAGCGCCGCGAGACCCT-3')
(underlined residues denote the EcoRV site). The resulting
PCR product was gel purified, cut with EcoRV, and
self-ligated. The resulting vector was pMB156. Due to primer locations
in secA2, pMB156 contains an in-frame deletion of 1,296 bp
in secA2. A SpeI-ScaI
secA2-containing fragment of pMB156 was subcloned into
SpeI-ScaI-cut pYUB657. The final vector was pMB160.
Electroporation of M. smegmatis. M. smegmatis strain mc2155 (45) was electroporated as previously described (36).
Two step allelic exchange to create
secA
mutants of M. smegmatis.
To construct
secA1 mutants, pMB128 was electroporated into
mc2155 and hygromycin-resistant transformants
were selected. Individual transformants were subjected to Southern
analysis, and 14 out of the 16 strains evaluated contained the suicide
vector integrated into the secA1 region of the chromosome by
means of a single-crossover event. One of these strains, MB526, was
employed in the subsequent steps. For the second homologous
recombination event, MB526 was first grown to saturation in 7H9 medium
with hygromycin at 50 µg/ml. For MB526 strains that additionally
carry kanamycin resistance element-containing plasmids,
kanamycin was included in this medium. This culture was subcultured at
a 1:100 dilution into the same medium lacking hygromycin and incubated
overnight. Dilutions were plated onto 7H10 plates containing 4.5%
sucrose to select for sucrose-resistant colonies. To obtain
secA2 mutants, pMB160 was electroporated into
mc2155 and hygromycin-resistant transformants
were obtained. Three out of three transformants were confirmed to be
the result of a single-crossover event by Southern analysis. One of
these clones, MB573, was used for the subsequent work presented in this
report. The second homologous recombination event was selected by using the protocol described above for MB526.
Southern analysis. To analyze secA1 recombinants, genomic DNA was isolated from M. smegmatis clones as previously described (10) and digested with BglII. The probe used was a 669-bp MscI fragment of pYUB536 containing secA1 of M. smegmatis. To analyze secA2 recombinants, genomic DNA was isolated and digested with BamHI. The probe used was a 1.9-kb BamHI-HindIII fragment obtained from pMB156 that contains secA2 of M. smegmatis. Southern analysis was performed as previously described (41), and probes were labeled with [32P]dCTP using the Ready-to-Go Labeling kit (Pharmacia).
Construction of 'phoA fusion vectors.
fbpB-'phoA, pepA-'phoA, and
rv1566c-'phoA fusions were rescued from strains
mc22718, mc22724, and
mc22725, respectively. These strains contain
M. tuberculosis DNA-'phoA fusions that encode
active PhoA fusion proteins in M. smegmatis and were
recently obtained from transposon libraries (5). These phoA fusions are present on cosmids integrated into the
chromosome. To rescue the fusions, genomic DNA was isolated from each
strain and digested with NarI (for
mc22718 and mc22725) or
NheI (for mc22724), self-ligated, and
transformed into DH5
. Due to the presence of an E. coli
origin of replication on the transposon, these self-ligated molecules
are replicative plasmids in E. coli. These restriction enzymes cut outside of the phoA fusion and promoter element.
Once isolated, the fusions were subcloned onto a mycobacterial shuttle vector, pMB198, that contains the attP/int L5
mycobacteriophage integration attachment system, which promotes
integration into the chromosome in single copy (25).
Isolation of azide-resistant alleles of M. bovis BCG SecA. Plasmid pYUB499 was subjected to N-methyl-N'-nitro-N-nitrosoguanidine (Sigma) mutagenesis (30). Mutagenized DNA was electroporated into mc2155, and azide-resistant cells were selected on 7H10 agar plates containing sodium azide at 25 µg/ml. This concentration of sodium azide was chosen on the basis of azide sensitivity disk assays that determined the minimum amount of sodium azide capable of inhibiting growth of M. smegmatis on 7H10 agar plates.
Azide sensitivity disk assays. Cells were grown in LB to saturation. A 0.1-ml volume of saturated culture was mixed with molten LB top agar and plated on an LB plate. Seven-millimeter-diameter paper filter disks (Schleicher & Schuell) were then placed on the hardened top agar. To each disk, 10 µl of 0.3 M sodium azide was added. The zone of sensitivity was calculated as the diameter of clearing around the disk minus the diameter of the disk.
Preparation of whole-cell protein extracts from M.
smegmatis and Western analysis.
Strains were grown to an
A600 of 0.5 to 1.0 in 7H9-1×
ADS-glycerol-0.1% Tween 80-kanamycin at 20 µg/ml. The same number
of cells, 1.2 × 109, was harvested by
centrifugation. The cells were washed twice in phosphate-buffered
saline-0.02% Tween 80, pelleted by centrifugation, quick-frozen in a
dry-ice -ethanol bath, and stored at
20°C. At a later time, the
pellets were resuspended in 200 µl of extraction buffer (50 mM
Tris-HCl [pH 7.5], 5 mM EDTA, 0.6% sodium dodecyl sulfate [SDS],
10 µg/ml aprotinin, E-64 at 10 µg/ml, leupeptin at 10 µg/ml,
Pefabloc SC at 500 µg/ml, pepstatin A at 10 µg/ml) to which 200 µl of 106-µm glass beads was added. The cells and beads were then
vortexed twice for 5 min at 4°C with a 5-min rest on ice. A 200-µl
volume of 2× SDS-polyacrylamide gel electrophoresis (PAGE) sample
buffer was added to each sample. The samples were denatured by boiling,
and 20 µl was loaded onto an SDS-PAGE gel. The proteins were
transferred to nitrocellulose, and Western analysis to detect PhoA or
hemagglutinin (HA) was carried out with anti-PhoA polyclonal
antibodies obtained from 5 Prime-3 Prime, Inc., or anti-HA monoclonal
antibodies obtained from Covance, Inc.
Nucleotide sequence accession numbers. The nucleotide sequences reported here have been submitted to the GenBank database and assigned the following accession numbers: M. smegmatis secA1, U66081; M. smegmatis secA2, AF287049; M. bovis BCG, U66080.
| |
RESULTS |
|---|
|
|
|---|
Cloning of mycobacterial secA homologues.
At
the start of this study, a minimal number of secA genes had
been cloned. By using available sequences from E. coli,
B. subtilis, and P. lutherii, degenerate
oligonucleotide primers were designed to a region of identity in the
amino termini of these proteins (see Materials and Methods). These
primers were used to amplify an approximately 250-bp PCR product from
both M. bovis BCG and M. smegmatis genomic DNAs.
The resulting PCR products were used to probe appropriate M. bovis BCG and M. smegmatis genomic libraries and led to
the cloning and sequencing of secA homologues from these two
mycobacterial species. These first secA genes we identified
are named secA1. M. bovis BCG secA1
and M. smegmatis secA1 encode proteins with predicted sizes
of 106 and 107 kDa, respectively. Subsequently, a secA1
homologue (rv3240c) was identified in the complete genome
sequence of M. tuberculosis (8). Each of these
secA1 genes encodes a protein with significant sequence
similarity to SecA1 in other mycobacterial species and to the SecA
proteins of other bacteria (Table 3).
Southern analysis with secA1 probes revealed hybridizing
restriction fragments in the genomic DNAs of all of the mycobacterial
species tested. This Southern analysis was consistent with
secA1 being a single-copy gene; there was no indication that
another secA gene existed in the mycobacterial genome (data
not shown).
|
|
Determination of the essentiality of secA1 and secA2. In other bacteria in which SecA has been studied, SecA is essential and encoded by a single-copy gene (17, 34, 43). One explanation for the presence of two secA genes in mycobacteria is that they encode redundant functions. In this scenario, deletion of either secA gene alone would not be lethal because the remaining homologue would compensate for the absence of the other. To determine the essential nature of each SecA protein in mycobacteria, we tested whether it is possible to delete either secA gene.
We used a two-step allelic-exchange strategy to determine the essentiality of each secA gene. This approach has previously been used in M. smegmatis (22, 36). In the first step, a suicide vector containing an in-frame deletion of a given secA gene, a selectable hyg (encoding hygromycin resistance) marker, and a counterselectable sacB marker is integrated into the chromosome by means of a single homologous recombination event between the secA allele on the vector and the wild-type secA allele in the chromosome. The resulting recombinant strain is referred to as a single-crossover strain, and it contains a tandem duplication of the secA region (both a mutated and a wild-type allele are present in the chromosome) separated by vector sequences including sacB and hyg (diagrams of such strains are shown in Fig. 2B and 3B). The second step is to select recombinants that have undergone a second homologous recombination event between the two secA alleles. Depending on the site of this second recombination event, it leaves either a mutant or a wild-type allele in the chromosome. This second recombination event also eliminates the intervening vector sequences, including sacB and hyg. Expression of sacB results in sensitivity to sucrose; therefore, these secondary recombinants are selected as sucrose-resistant colonies (38). The failure to obtain recombinants in which the secA gene is deleted strongly suggests that it is an essential gene. If the inability to delete the chromosomal secA gene is overcome in merodiploid strains that contain an extra copy of secA, it demonstrates the absolute requirement of that secA gene for viability.
|
|
secA1 is essential in M. smegmatis. We first applied this approach to the secA1 gene of M. smegmatis. Suicide plasmid pMB128 contains a 1,278-bp in-frame deletion within M. smegmatis secA1. This deletion will generate a mutated protein comprising 531 amino acids (in comparison to the wild-type protein of 957 amino acids). Importantly, the deletion involves both ATP-binding sites (Fig. 1). This plasmid was electroporated into M. smegmatis, and hygromycin-resistant transformants were obtained. One of these transformants, MB526, was used in the subsequent experiments. MB526 is the product of a single-crossover event between the secA1 deletion allele on pMB128 and the wild-type secA1 allele on the chromosome, as demonstrated by Southern analysis (Fig. 2B and E).
Following the growth of MB526 in the absence of hygromycin, sucrose-resistant colonies were selected and then screened for hygromycin sensitivity. Sucrose-resistant and hygromycin-sensitive colonies have undergone a second recombination event between the two secA1 alleles. The individual secA1 allele remaining in the resulting recombinants was assayed by PCR and Southern analysis. All of the recombinants assayed contained the wild-type allele (Table 4). This failure to obtain secA1 deletion mutants strongly suggests that deletion of secA1 in M. smegmatis is a lethal event.
|
secA1 recombinants and wild-type secA1
recombinants (Table 4; Fig. 2). From these results, we concluded that
secA1 is an essential gene in M. smegmatis.
secA2 cannot functionally replace
secA1.
The essentiality of secA1 in
M. smegmatis suggested that secA1 and
secA2 are not redundant genes. However, if secA2
is not expressed under these experimental conditions, secA1
and secA2 might still have the same function. To address
this possibility, we tested whether a
secA1 strain can be
rescued by secA2 expression. Single-crossover strain MB526
was independently electroporated with the plasmids pMB208, pMB147, and
pMB162, which all carry the secA2 gene under control of the
constitutive hsp60 promoter. Vector pMB208 is a multicopy
vector expressing M. smegmatis secA2, while
pMB147 and pMB162 are multicopy and single-copy vectors, respectively,
that express M. tuberculosis secA2. Secondary
recombination products were selected from these recombinant strains.
None of these secA2 expression constructs enabled the
production of
secA1 mutants (Table 4).
secA2 is not essential in M.
smegmatis.
The essential nature of secA2 in
M. smegmatis was also evaluated. Suicide plasmid pMB160
contains an in-frame deletion of 1,296 bp within M. smegmatis
secA2. This deletion produces a mutated protein of 366 amino acids
(in comparison to the wild-type protein of 798 amino acids). Once
again, the ATP-binding sites are included in the deletion (Fig. 1). By
using pMB160, single-crossover strain MB573 was constructed (Fig. 3).
From MB573, sucrose-resistant and hygromycin-sensitive secondary
recombinants were identified. Some of these recombinants contained
the
secA2 deletion. One of these
secA2 mutants, mc22522, was used in
all of the subsequent analyses presented in this report. A separate
secA2 single-crossover strain, MB575, similarly led to the
production of
secA2 mutants. The ability to delete
secA2 demonstrates that it is not an essential gene. To our
knowledge, this is the first secA that has been shown to be nonessential.
The
secA2 mutant exhibits a growth defect on rich
agar plates.
Shortly after generating
mc22522, we observed that when grown on rich
medium (LB or Mueller-Hinton) agar plates, it produces smaller single
colonies than those of wild-type M. smegmatis strain mc2155 (Fig. 4).
This small-colony phenotype is medium dependent; it is not seen on
minimal agar plates (7H10). Furthermore, there is no observable growth
defect associated with mc22522 when it is grown
in rich liquid medium.
|
secA2 phenotype was seen only on rich agar plates and was specific for a
secA2 background, since overexpression of
secA1 in wild-type parent strain
mc2155 has no obvious effect on colony size. This
synthetic phenotype between
secA2 and high-level
expression of secA1 is suggestive of a relationship between
these two genes.
|
The
secA2 mutant is supersensitive to azide.
In E. coli, sodium azide inhibits protein export both in
vivo and in vitro (35). Furthermore, SecA has been shown
to be the major essential target of sodium azide, as azide-resistant mutants map to secA in E. coli (21,
35). Therefore, we investigated whether the presence of SecA2
influences the azide sensitivity of M. smegmatis.
4. The azide
resistance of one transformant was shown to segregate with the
mutagenized plasmid, designated pYUB538, by means of retransformation
experiments. Sequence analysis of the secA1 gene on pYUB538
revealed a G-to-A mutation at base pair 386. This mutation results in
replacement of threonine 129 with isoleucine in ABCI (Fig. 1). The
corresponding mutation in secA of B. subtilis,
replacement of threonine 128 with isoleucine, has previously been
reported to produce azide resistance (32). Thus, this test
provided compelling evidence that sodium azide acts in a similar
fashion on SecA1 in mycobacteria.
To measure the impact of SecA2 on the azide sensitivity of M. smegmatis, a disk assay was employed (see Materials and Methods). The zone of clearing around an azide-soaked disk was used as the measure of azide sensitivity. This assay clearly demonstrated that the
secA2 mutant is supersensitive to azide. While wild-type mc2155 had a zone of sensitivity of 17.7 mm,
mc22522 exhibited a 31.3-mm zone of sensitivity.
The complemented strain, mc22522 with pMB162,
exhibited an intermediate zone of sensitivity of 20.3 mm. This
increased azide sensitivity of mc22522 was
similarly observed in a liquid MIC analysis (data not shown). This
supersensitivity phenotype is specific to azide and is not a
pleiotropic effect of altered cell wall permeability. The sensitivity
of mc22522 to a collection of drugs including
streptomycin, isoniazid, rifampin, ampicillin, and vancomycin was
unchanged. Given the relationship between azide and SecA, we believe
that this supersensitivity phenotype reflects a role for SecA2 in
assisting SecA1 in the essential Sec pathway.
SecA2 functions in protein export. The azide supersensitivity phenotype suggested that SecA2 plays a role in assisting SecA1 in protein export. The strong homology of SecA2 to other SecA proteins also suggested a role in protein export. Therefore, we set out to determine whether cells lacking secA2 exhibit a defect in protein export.
To monitor protein export, we used immunoblot analysis of exported PhoA (E. coli alkaline phosphatase) fusion proteins to ascertain whether protein export occurs normally or whether unprocessed precursor proteins accumulate intracellularly (indicative of a defect in protein export). Each of the fusions analyzed had an exported M. tuberculosis protein (FbpB [antigen 85B, Rv1886c], Rv1566c, or PepA [Rv0125]) fused at the amino terminus of a truncated PhoA protein lacking its endogenous signal sequence. These fusions were recently isolated in a genetic screen to identify M. tuberculosis proteins that are exported in the host strain of M. smegmatis (5). We, and others, have observed that often when exported PhoA fusion proteins are expressed in M. smegmatis and detected by Western analysis of whole-cell extracts, the products identified do not migrate at the expected molecular weight of the fusion protein (6, 49). Rather, different fusion proteins lead to the production of similar, smaller PhoA-reactive products that are near the size expected for native PhoA. Although the size of these products is unexpected, we believe that they reflect exported PhoA fusions. This is based on the findings that these PhoA fusion proteins exhibit phosphatase activity (indicating export out of the cytoplasm) and that they contain recognizable signal sequences. We propose that these smaller PhoA-reactive products arise by proteolysis that occurs following export to the cell wall. In E. coli, a similar proteolytic degradation near the PhoA fusion junction of some exported PhoA fusion proteins has been observed (23). Given this property of PhoA fusions in M. smegmatis, we predicted that a defect in the export of these proteins would result in a decrease in the degradation of the fusions, yielding an increase in the amount of full-length fusion inside the cells. When either the FbpB-HA-'PhoA or the Rv1566c-'PhoA fusion is expressed in wild-type mc2155, bands between 45 and 50 kDa are observed but no full-length fusion product is observed (Fig. 6A, lanes 3 and 6). In contrast, when these same fusion proteins are expressed in the
secA2
mutant (mc22522), the correct-sized full-length
fusion product (76.4 kDa for FbpB-HA-'PhoA or 64.7 kDa for
Rv1566c-'PhoA) is observed, along with a reduced amount of the
proteolytic PhoA products (Fig. 6A, lanes 5 and 8). We interpret this
change in size as reflecting the accumulation of the full-length fusion
product in the cytoplasm, where it is protected from cell wall
proteases, and showing that mc22522 exhibits a
defect in the export of these two fusion proteins.
|
| |
DISCUSSION |
|---|
|
|
|---|
Mycobacteria have two different SecA proteins. The proper localization of cell surface and secreted proteins is an important aspect of mycobacterial physiology and pathogenesis. The cell envelope of mycobacteria is an unusual structure that presents unique barriers to protein secretion. Yet, the protein export pathways of mycobacteria have remained uncharacterized (5). The genome of M. tuberculosis contains homologues of all of the Sec pathway components (5, 8), with the exception of SecB, a protein that is not found in all Sec systems (19). In addition, mycobacteria are known to secrete proteins that are initially synthesized as precursors containing recognizable signal sequences at their amino termini. Simply based on this information, it might appear that mycobacteria contain a typical Sec pathway for protein export beyond the cytoplasm. However, as presented in this report, the mycobacterial Sec pathway is unusual in that it has two SecA proteins. Although SecA is ubiquitously present and highly conserved in bacteria, the identification of organisms containing two secA genes is new.
Both the mycobacterial SecA1 and SecA2 proteins exhibit significant sequence similarity to other bacterial and plant (plastid) SecA homologues, and both contain the hallmark ATP-binding motifs (Table 3; Fig. 1). All of the mycobacteria evaluated so far have both secA1 and secA2, including M. leprae (9, 26). This is significant, given the reductive evolution that has been documented in M. leprae
a smaller
genome size and 44% of the genes being recognizable pseudogenes
(9). The evolutionary basis for two SecA proteins in
mycobacteria is unknown. If the two genes arose by a duplication event,
it likely took place a long time ago since the two SecA proteins are
not extremely similar to each other, but each is highly conserved in
different mycobacterial species. SecA1 exhibits higher sequence
similarity with the other SecA homologues, including that of the
distantly related bacteria E. coli and B. subtilis, than it does with mycobacterial SecA2 (Table 3).
SecA1 is a housekeeping SecA protein, and SecA2 is an extra SecA protein. As a starting point for defining the roles played by SecA1 and SecA2, we used allelic exchange to determine whether each secA gene is essential. These experiments showed that while secA1 is essential in M. smegmatis, secA2 is not. In other bacteria, SecA is essential.
The essentiality of SecA1 leads us to believe that it represents the mycobacterial equivalent of E. coli SecA or the housekeeping SecA protein. Our isolation of azide-resistant mutations in SecA1 also supports this idea. We believe that SecA1 acts together with the other mycobacterial Sec family homologues to transport signal sequence-containing proteins across the cytoplasmic membrane. However, definitive evidence that SecA1 functions in this manner requires further investigation and the construction of a conditional secA1 allele. Our ability to generate a
secA2 mutant demonstrates that
SecA2 is not essential. Although this mutation is not a full deletion, we do not believe that the truncated protein retains its function. Of
the two ATP-binding sites, all but the A motif of ABCI is deleted, which should eliminate all ATP-binding and hydrolysis activity (Fig.
1). Furthermore, we have subsequently constructed a mutant of M. tuberculosis with a complete deletion of secA2 that is
also viable (M. Braunstein and W. R. Jacobs, unpublished data). To our knowledge, this is the first SecA protein that has been shown to be nonessential.
The role of SecA2 in mycobacteria. To begin to understand the role of SecA2 in the cell, we examined whether SecA2 is capable of carrying out the same functions as SecA1. The fact that a mutant with a deletion of secA1 is inviable suggested that SecA2 is not simply an equivalent copy of SecA1. However, it remained a possibility that this result reflected a lack of expression of SecA2 under these experimental conditions. To address this directly, we expressed secA2 from the constitutive mycobacterial hsp60 promoter. By Western analysis, we saw that the SecA2 protein was produced (data not shown); however, the requirement for SecA1 was not relieved by this expression of SecA2. This finding that SecA2 cannot functionally replace SecA1 is consistent with the fact that the homology shared between the two SecA proteins is only 50% (Table 3).
If SecA2 is not simply an extra copy of SecA1, what is the role of SecA2? Based on the significant sequence homology between SecA2 and other SecA homologues, we believed it would be involved in protein export
perhaps the export of a specific subset of proteins. Our
subsequent analysis supports this idea.
A phenotypic analysis of
secA2 mutant
mc22522 revealed phenotypes that include a growth
defect on rich agar plates. The source of the phenotype is unclear.
This growth phenotype of mc22522 is exacerbated
when secA1 is overexpressed, but overexpression of
secA1 in a wild-type background does not have the same
effect. This synthetic relationship between high levels of SecA1 and
the absence of SecA2 suggests that these two SecA proteins interact with some of the same proteins or each other. This is consistent with a
role for SecA2 in protein export. A possible explanation for this
synthetic phenotype is that when SecA2 is absent and SecA1 is
overexpressed, nonproductive complexes between SecA1 and other
essential Sec factors arise, leading to an overall decrease in the
efficiency of protein export. This possibility will be explored in
future experiments.
The azide supersensitivity phenotype of mc22522
also suggests an involvement of SecA2 in protein export. Azide poisons
ATPases, and SecA1 appears to be the most sensitive essential ATPase in mycobacteria. For this reason, we interpret this phenotype as indicative that azide has a greater effect on the Sec pathway when
SecA2 is not present to assist in the process.
The most direct experiment we undertook to identify a role for SecA2 in
the export of proteins was to monitor protein processing as a measure
of protein translocation across the cytoplasmic membrane. In looking at
the steady-state levels of three PhoA fusion proteins, we found that an
FbpB-HA-'PhoA fusion and an Rv1566c-'PhoA fusion are not as efficiently
exported in the
secA2 mutant. It is important to
emphasize that this export defect of mc22522 is
not complete. The immunoblots reveal a reduced amount of export (PhoA
proteolytic products), and the mc22522 strains
expressing these fusions still exhibit phosphatase activity (which is
associated with transport of the fusion protein out of the cytoplasm).
In contrast, we did not see any evidence of a defect in the export of a
PepA-'PhoA fusion protein in mc22522. This
finding reveals that SecA2 participates in the protein export of some,
perhaps not all, signal sequence-containing proteins.
We interpret our results as indicating a role for SecA2 in protein
export. An alternative explanation could be that SecA2 is a regulator
of the level of SecA1. This idea is supported by the demonstration in
E. coli that SecA can regulate its own expression (44). In examining Western analyses with the currently
available reagents, there is no indication that the levels of SecA1 are altered by the presence or absence of SecA2 in the cell; therefore, we
think this explanation for the role of SecA2 unlikely (data not shown).
Two roles for SecA2 in mycobacteria. We propose that one role for SecA2 is as a facilitator of protein export via the primary Sec pathway involving SecA1. We believe that the azide supersensitivity phenotype and export defect of some signal sequence-containing PhoA fusion proteins reflect this role of SecA2. There may be a collection of signal sequence-containing presecretory proteins that are substrates for both SecA1 and SecA2. Thus, when SecA2 is absent, there is an impact on the overall efficiency of the pathway. We propose that FbpB-'PhoA and Rv1566c-'PhoA are two such proteins, since SecA2 participates, but dos not exclusively act, in their export. In E. coli, B. subtilis, and Streptomyces lividans, SecA has been shown to exist as a dimer (1, 3, 13, 47). Therefore, it is also possible that SecA1 and SecA2 form mixed dimers and that this species is important in the recognition of certain substrates.
The findings that SecA2 cannot functionally replace SecA1 and that SecA2 is highly conserved throughout mycobacteria lead us to believe that SecA2 has a second role in the cell. This second role may be in the export of a distinct subset of proteins that are exclusive or preferential substrates of SecA2. The identities of those proteins have not been established, and their identification awaits a more complete analysis of the multitude of exported proteins. In order to identify these proteins, it will be important to know the conditions under which SecA2-specific protein export functions. Research on numerous bacterial pathogens has repeatedly demonstrated the importance of specialized protein secretion systems to virulence. Many of the specialized export pathways are present in pathogenicity islands. The genome of M. tuberculosis does not appear to have specialized export systems homologous to those previously identified in other pathogens (4). However, the recent identification of two secA genes in the gram-positive pathogens S. aureus and S. pneumoniae raises the interesting possibility that SecA2 is a component of a new type of specialized protein export pathway that is important to pathogenesis (24, 27, 48). SecA2 may represent a protein that has maintained some of its abilities to function with SecA1 and the other Sec family homologues in the primary Sec pathway but has evolved to have a second function that is utilized under a certain set of conditions to export a specific subset of proteins.| |
ACKNOWLEDGMENTS |
|---|
We gratefully acknowledge F. C. Bange and V. Balasubramanian for genomic libraries, T. Weisbrod for assistance with DNA sequencing, and A. Flower and M. Pavelka for critical reading of the manuscript.
This work was supported by NIH grant AI21670 to W.R.J. M.B. was a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation during the course of this work.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27599-7290. Phone: (919) 966-5051. Fax: (919) 962-8103. E-mail: braunste{at}med.unc.edu.
Present address: Aaron Diamond AIDS Research Center, New York, NY 10016.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Akita, M., A. Shinkai, S. Matsuyama, and S. Mizushima. 1991. SecA, an essential component of the secretory machinery of Escherichia coli, exists as homodimer. Biochem. Biophys. Res. Commun. 174:211-216[CrossRef][Medline]. |
| 2. |
Berthet, F. X.,
M. Lagranderie,
P. Gounon,
C. Laurent-Winter,
D. Ensergueix,
P. Chavarot,
F. Thouron,
E. Maranghi,
V. Pelicic,
D. Portnoi,
G. Marchal, and B. Gicquel.
1998.
Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene.
Science
282:759-762 |
| 3. |
Blanco, J.,
A. J. Driessen,
J. J. Coque, and J. F. Martin.
1998.
Biochemical characterization of the SecA protein of Streptomyces lividans interaction with nucleotides, binding to membrane vesicles and in vitro translocation of proAmy protein.
Eur. J. Biochem.
257:472-478[Medline].
|
| 4. | Braunstein, M., and J. T. Belisle. 2000. Genetics of protein secretion, p. 203-220. In G. F. Hatfull, and W. R. J. Jacobs (ed.), Molecular genetics of mycobacteria. ASM Press, Washington, D.C. |
| 5. |
Braunstein, M.,
T. I. Griffin,
J. I. Kriakov,
S. T. Friedman,
N. D. Grindley, and W. R. Jacobs, Jr.
2000.
Identification of genes encoding exported Mycobacterium tuberculosis proteins using a Tn552'phoA in vitro transposition system.
J. Bacteriol.
182:2732-2740 |
| 6. | Carroll, J. D., R. C. Wallace, J. Keane, H. G. Remold, and R. D. Arbeit. 2000. Identification of Mycobacterium avium DNA sequences that encode exported proteins by using phoA gene fusions. Tuber. Lung. Dis. 80:117-130[CrossRef][Medline]. |
| 7. |
Cirillo, J. D.,
T. R. Weisbrod,
A. Banerjee,
B. R. Bloom, and W. R. Jacobs, Jr.
1994.
Genetic determination of the meso-diaminopimelate biosynthetic pathway of mycobacteria.
J. Bacteriol.
176:4424-4429 |
| 8. | Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry, III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, B. G. Barrell, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544[CrossRef][Medline]. |
| 9. | Cole, S. T., K. Eiglmeier, J. Parkhill, K. D. James, N. R. Thomson, P. R. Wheeler, N. Honore, T. Garnier, C. Churcher, D. Harris, K. Mungall, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. M. Davies, K. Devlin, S. Duthoy, T. Feltwell, A. Fraser, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, C. Lacroix, J. Maclean, S. Moule, L. Murphy, K. Oliver, M. A. Quail, M. A. Rajandream, K. M. Rutherford, S. Rutter, K. Seeger, S. Simon, M. Simmonds, J. Skelton, R. Squares, S. Squares, K. Stevens, K. Taylor, S. Whitehead, J. R. Woodward, and B. G. Barrell. 2001. Massive gene decay in the leprosy bacillus. Nature 409:1007-1011[CrossRef][Medline]. |
| 10. | Connell, N. D. 1994. Mycobacterium: isolation, maintenance, transformation, and mutant selection. Methods Cell Biol. 45:108-125. |
| 11. | Danese, P. N., and T. J. Silhavy. 1998. Targeting and assembly of periplasmic and outer-membrane proteins in Escherichia coli. Annu. Rev. Genet. 32:59-94[CrossRef][Medline]. |
| 12. | Donnelly-Wu, M. K., W. R. Jacobs, Jr., and G. F. Hatfull. 1993. Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria. Mol. Microbiol. 7:407-417[CrossRef][Medline]. |
| 13. | Driessen, A. J. 1993. SecA, the peripheral subunit of the Escherichia coli precursor protein translocase, is functional as a dimer. Biochemistry 32:13190-13197[CrossRef][Medline]. |
| 14. | Duong, F., and W. Wickner. 1997. Distinct catalytic roles of the SecYE, SecG and SecDFyajC subunits of preprotein translocase holoenzyme. EMBO J. 16:2756-2768[CrossRef][Medline]. |
| 15. | Economou, A. 1998. Bacterial preprotein translocase: mechanism and conformational dynamics of a processive enzyme. Mol. Microbiol. 27:511-518[CrossRef][Medline]. |
| 16. | Economou, A. 2000. Bacterial protein translocase: a unique molecular machine with an army of substrates. FEBS Lett. 476:18-21[CrossRef][Medline]. |
| 17. | Economou, A. 1999. Following the leader: bacterial protein export through the Sec pathway. Trends Microbiol. 7:315-320[CrossRef][Medline]. |
| 18. | Economou, A., and W. Wickner. 1994. SecA promotes preprotein translocation by undergoing ATP-driven cycles of membrane insertion and deinsertion. Cell 78:835-843[CrossRef][Medline]. |
| 19. |
Fekkes, P., and A. J. Driessen.
1999.
Protein targeting to the bacterial cytoplasmic membrane.
Microbiol. Mol. Biol. Rev.
63:161-173 |
| 20. | Finlay, B. B., and S. Falkow. 1997. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61:136-169[Abstract]. |
| 21. |
Fortin, Y.,
P. Phoenix, and G. R. Drapeau.
1990.
Mutations conferring resistance to azide in Escherichia coli occur primarily in the secA gene.
J. Bacteriol.
172:6607-6610 |
| 22. | Gomez, M., L. Doukhan, G. Nair, and I. Smith. 1998. sigA is an essential gene in Mycobacterium smegmatis. Mol. Microbiol. 29:617-628[CrossRef][Medline]. |
| 23. | Kaufman, M. R., and R. K. Taylor. 1994. Identification of bacterial cell-surface virulence determinants with TnphoA. Methods Enzymol. 235:426-448[Medline]. |
| 24. | Kuroda, M., T. Ohta, I. Uchiyama, T. Baba, H. Yuzawa, I. Kobayashi, L. Cui, A. Oguchi, K. Aoki, Y. Nagai, J. Lian, T. Ito, M. Kanamori, H. Matsumaru, A. Maruyama, H. Murakami, A. Hosoyama, Y. Mizutani-Ui, N. K. Takahashi, T. Sawano, R. Inoue, C. Kaito, K. Sekimizu, H. Hirakawa, S. Kuhara, S. Goto, J. Yabuzaki, M. Kanehisa, A. Yamashita, K. Oshima, K. Furuya, C. Yoshino, T. Shiba, M. Hattori, N. Ogasawara, H. Hayashi, and K. Hiramatsu. 2001. Whole genome sequencing of methicillin-resistant Staphylococcus aureus. Lancet 357:1225-1240[CrossRef][Medline]. |
| 25. |
Lee, M. H.,
L. Pascopella,
W. R. Jacobs, Jr., and G. F. Hatfull.
1991.
Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guerin.
Proc. Natl. Acad. Sci. USA
88:3111-3115 |
| 26. | Limia, A., F. J. Sangari, D. Wagner, and L. E. Bermudez. 2001. Characterization and expression of secA in Mycobacterium avium. FEMS Microbiol. Lett. 197:151-157[CrossRef][Medline]. |
| 27. | Mazmanian, S. K., H. Ton-That, and O. Schneewind. 2001. Sortase-catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus. Mol. Microbiol. 40:1049-1057[CrossRef][Medline]. |
| 28. | Mecsas, J. J., and E. J. Strauss. 1996. Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands. Emerg. Infect. Dis. 2:270-288[Medline]. |
| 29. | Miller, J. F., and P. Cossart. 1999. Bacterial pathogenesis: before the post-genomic era. Curr. Opin. Microbiol. 2:15-17. |
| 30. | Miller, J. H. 1992. A short course in bacterial genetics: a laboratory manual and handbook for Escherichia coli and related bacteria. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 31. | Mitchell, C., and D. Oliver. 1993. Two distinct ATP-binding domains are needed to promote protein export by Escherichia coli SecA ATPase. Mol. Microbiol. 10:483-497[Medline]. |
| 32. | Nakane, A., H. Takamatsu, A. Oguro, Y. Sadaie, K. Nakamura, and K. Yamane. 1995. Acquisition of azide-resistance by elevated SecA ATPase activity confers azide-resistance upon cell growth and protein translocation in Bacillus subtilis. Microbiology 141:113-121[Abstract]. |
| 33. | Oliver, D. B. 1993. SecA protein: autoregulated ATPase catalysing preprotein insertion and translocation across the Escherichia coli inner membrane. Mol. Microbiol. 7:159-165[CrossRef][Medline]. |
| 34. | Oliver, D. B., and J. Beckwith. 1981. E. coli mutant pleiotropically defective in the export of secreted proteins. Cell 25:765-772[CrossRef][Medline]. |
| 35. |
Oliver, D. B.,
R. J. Cabelli,
K. M. Dolan, and G. P. Jarosik.
1990.
Azide-resistant mutants of Escherichia coli alter the SecA protein, an azide-sensitive component of the protein export machinery.
Proc. Natl. Acad. Sci. USA
87:8227-8231 |
| 36. |
Pavelka, M. S., Jr., and W. R. Jacobs, Jr.
1996.
Biosynthesis of diaminopimelate, the precursor of lysine and a component of peptidoglycan, is an essential function of Mycobacterium smegmatis.
J. Bacteriol.
178:6496-6507 |
| 37. |
Pavelka, M. S., Jr., and W. R. Jacobs, Jr.
1999.
Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis, bacillus Calmette-Guerin, and Mycobacterium tuberculosis H37Rv by allelic exchange.
J. Bacteriol.
181:4780-4789 |
| 38. |
Pelicic, V.,
J. M. Reyrat, and B. Gicquel.
1996.
Expression of the Bacillus subtilis sacB gene confers sucrose sensitivity on mycobacteria.
J. Bacteriol.
178:1197-1199 |
| 39. | Pohlschroder, M., W. A. Prinz, E. Hartmann, and J. Beckwith. 1997. Protein translocation in the three domains of life: variations on a theme. Cell 91:563-566[CrossRef][Medline]. |
| 40. | Roux, K. H. 1994. Using mismatched primer-template pairs in touchdown PCR. BioTechniques 16:812-814[Medline]. |
| 41. | Sambrook, J. E., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 42. | Schiebel, E., A. J. Driessen, F. U. Hartl, and W. Wickner. 1991. Delta mu H+ and ATP function at different steps of the catalytic cycle of preprotein translocase. Cell 64:927-939[CrossRef][Medline]. |
| 43. | Schmidt, M. G., and K. B. Kiser. 1999. SecA: the ubiquitous component of preprotein translocase in prokaryotes. Microbes Infect. 1:993-1004[CrossRef][Medline]. |
| 44. |
Schmidt, M. G., and D. B. Oliver.
1989.
SecA protein autogenously represses its own translation during normal protein secretion in Escherichia coli.
J. Bacteriol.
171:643-649 |
| 45. | Snapper, S. B., R. E. Melton, S. Mustafa, T. Kieser, and W. R. Jacobs, Jr. 1990. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol. Microbiol. 4:1911-1919[Medline]. |
| 46. | Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, et al. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460[CrossRef][Medline]. |
| 47. |
Takamatsu, H.,
A. Nakane,
A. Oguro,
Y. Sadaie,
K. Nakamura, and K. Yamane.
1994.
A truncated Bacillus subtilis SecA protein consisting of the N-terminal 234 amino acid residues forms a complex with Escherichia coli SecA51(ts) protein and complements the protein translocation defect of the secA51 mutant.
J. Biochem. (Tokyo)
116:1287-1294 |
| 48. | Tettelin, H., K. E. Nelson, I. T. Paulsen, J. A. Eisen, T. D. Read, S. Peterson, J. Heidelberg, R. T. DeBoy, D. H. Haft, R. J. Dodson, A. S. Durkin, M. Gwinn, J. F. Kolonay, W. C. Nelson, J. D. Peterson, L. A. Umayam, O. White, S. L. Salzberg, M. R. Lewis, D. |